Valneva SE

1.7830

02-December-24 11:29:55

15 minutes delayed

Stocks

-0.0570

-3.10%

Today's range

1.7830 - 1.8450

ISIN

FR0004056851

Source

Cboe

Valneva Announces the Availability of Documentation for its Shareholder Meetings

02 Jun 2022 14:50:00 By Nasdaq GlobeNewswire
Valneva Appoints Dr. Thomas Decker and Dr. Michael Pfleiderer to its Scientific Advisory Board

31 May 2022 11:45:00 By Nasdaq GlobeNewswire
Valneva Successfully Completes Lot-to-Lot Consistency Trial for its Single-Shot Chikungunya Vaccine Candidate

25 May 2022 01:00:00 By Nasdaq GlobeNewswire
EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate

19 May 2022 01:00:00 By Nasdaq GlobeNewswire
Valneva Receives Notice of European Commission’s Intent to Terminate COVID-19 Vaccine Purchase Agreement

16 May 2022 01:15:00 By Nasdaq GlobeNewswire
Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

16 May 2022 01:00:00 By Nasdaq GlobeNewswire
Valneva Reports Q1 2022 Results and Provides Corporate Updates

05 May 2022 01:00:00 By Nasdaq GlobeNewswire
Valneva Initiates Heterologous Booster Trial of Inactivated, COVID-19 Vaccine Candidate

04 May 2022 11:45:00 By Nasdaq GlobeNewswire
VALNEVA Declaration of shares and voting rights - April 30, 2022

03 May 2022 12:00:00 By Nasdaq GlobeNewswire
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

26 Apr 2022 01:00:00 By Nasdaq GlobeNewswire

<<
<
4
5
6
7
8
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.